Literature DB >> 16860611

Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.

Sakarin Chanwong1, Niwat Maneekarn, Luksana Makonkawkeyoon, Sanit Makonkawkeyoon.   

Abstract

Intracellular growth of Mycobacterium tuberculosis in human and rabbit monocytes and in mouse and guinea pig macrophages was evaluated. Monocytes or macrophages were infected with M. tuberculosis H37Rv with the multiplicity of infection at 10 mycobacteria per monocyte. The average percentages of infected human and rabbit monocytes were 22% and 19%, while mouse and guinea pig macrophages were 46% and 58%, respectively. The average generation times of M. tuberculosis H37Rv inside human and rabbit monocytes and in mouse and guinea pig macrophages, after culturing the infected cells for 10 days, were 33.4, 50.3, 31.4, and 25.6 h, respectively. Using infected guinea pig macrophages for intracellular evaluation of drug susceptibility, the minimal inhibitory concentrations (MICs) of isoniazid to the intracellular and extracellular M. tuberculosis H37Rv were 0.1 and 0.4 microg/ml, while the MICs of rifampicin were 0.1 and 0.2 microg/ml, respectively. The minimal bactericidal concentrations (MBCs) of isoniazid to the intracellular and extracellular H37Rv were 0.2 and 0.4 microg/ml, while the MCSs of rifampicin were 0.1 and 0.2 microg/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860611     DOI: 10.1016/j.tube.2006.06.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  12 in total

1.  Classic reaction kinetics can explain complex patterns of antibiotic action.

Authors:  Pia Abel Zur Wiesch; Sören Abel; Spyridon Gkotzis; Paolo Ocampo; Jan Engelstädter; Trevor Hinkley; Carsten Magnus; Matthew K Waldor; Klas Udekwu; Ted Cohen
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

2.  Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages.

Authors:  Sharad Pathak; Tore Wentzel-Larsen; Birgitta Asjö
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

3.  1,4-Benzoquinone antimicrobial agents against Staphylococcus aureus and Mycobacterium tuberculosis derived from scorpion venom.

Authors:  Edson Norberto Carcamo-Noriega; Shyam Sathyamoorthi; Shibdas Banerjee; Elumalai Gnanamani; Monserrat Mendoza-Trujillo; Dulce Mata-Espinosa; Rogelio Hernández-Pando; José Ignacio Veytia-Bucheli; Lourival D Possani; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

4.  Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis.

Authors:  Vipul K Singh; Abhishek Mishra; Steven Bark; Arunmani Mani; Selvakumar Subbian; Robert L Hunter; Chinnaswamy Jagannath; Arshad Khan
Journal:  Microbes Infect       Date:  2020-06-17       Impact factor: 2.700

5.  Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis.

Authors:  Santosh Wagh; Chetan Rathi; Pradeep B Lukka; Keyur Parmar; Zaid Temrikar; Jiuyu Liu; Michael S Scherman; Richard E Lee; Gregory T Robertson; Anne J Lenaerts; Bernd Meibohm
Journal:  Antimicrob Agents Chemother       Date:  2021-08-23       Impact factor: 5.191

6.  Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.

Authors:  Flavia Sorrentino; Ruben Gonzalez del Rio; Xingji Zheng; Jesus Presa Matilla; Pedro Torres Gomez; Maria Martinez Hoyos; Maria Esther Perez Herran; Alfonso Mendoza Losana; Yossef Av-Gay
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

7.  Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies.

Authors:  Wipaporn Rojanarat; Narumon Changsan; Ekawat Tawithong; Sirirat Pinsuwan; Hak-Kim Chan; Teerapol Srichana
Journal:  Int J Mol Sci       Date:  2011-07-07       Impact factor: 5.923

8.  Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice.

Authors:  Yan Liang; Xuejuang Bai; Junxian Zhang; Jingying Song; Yourong Yang; Qi Yu; Ning Li; Xueqiong Wu
Journal:  Mol Med Rep       Date:  2016-06-03       Impact factor: 2.952

9.  The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB.

Authors:  Dominique Cadosch; Pia Abel Zur Wiesch; Roger Kouyos; Sebastian Bonhoeffer
Journal:  PLoS Comput Biol       Date:  2016-03-11       Impact factor: 4.475

10.  Improving the Potency of N-Aryl-2,5-dimethylpyrroles against Multidrug-Resistant and Intracellular Mycobacteria.

Authors:  Meir Touitou; Fabrizio Manetti; Camila Maringolo Ribeiro; Fernando Rogerio Pavan; Nicolò Scalacci; Katarina Zrebna; Neelu Begum; Dorothy Semenya; Antima Gupta; Sanjib Bhakta; Timothy D McHugh; Hanoch Senderowitz; Melina Kyriazi; Daniele Castagnolo
Journal:  ACS Med Chem Lett       Date:  2019-12-10       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.